Immunic Inc. (IMUX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Immunic Inc.

    NASDAQ: IMUX · Real-Time Price · USD
    0.98
    0.02 (1.73%)
    At close: Oct 03, 2025, 3:59 PM
    0.99
    1.18%
    Pre-market: Oct 06, 2025, 08:41 AM EDT

    Immunic Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1 -0.71 -0.37 -2.44
    PEG Ratio
    		 0.02 0.02 0.10 -0.06
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 5.44 2.30 0.39 1.78
    P/FCF Ratio
    		 -1.18 -0.93 -0.68 -2.72
    P/OCF Ratio
    		 -1.18 -0.94 -0.68 -2.72
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.05 0.05 0.01 0.01
    Quick Ratio
    		 1.77 2.12 9.20 9.40
    Current Ratio
    		 1.77 2.12 9.62 9.21
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -114.78 n/a
    Return on Equity
    		 -5.45 -3.24 -1.06 -0.73
    Return on Assets
    		 -2.46 -1.72 -0.94 -0.67
    Return on Invested Capital
    		 -5.05 -3.28 -1.32 -0.71
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist